HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC
Status:
Recruiting
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) compared with transarterial chemoembolization (TACE) in patients with
BCLC stage hepatocellular carcinoma (HCC).
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Dongguan People's Hospital First Affiliated Hospital Xi'an Jiaotong University First Affiliated Hospital, Sun Yat-Sen University Guangzhou No.12 People's Hospital Kaiping Central Hospital The First Affiliated Hospital of University of South China